Influx Healthtech Ltd IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | 2,895,600 (47%) | — | ₹2,780 Cr |
| NII (HNI) | — | 870,000 (14%) | — | ₹835 Cr |
| Retail | — | 2,029,200 (33%) | — | ₹1,948 Cr |
| Market Maker | — | 306,000 (5%) | — | ₹29 Cr |
| Σ Total | — | 6,100,800 (100%) | — | ₹58,568 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 1,200 | ₹115,200 |
| Retail (Max) | 13 | 15,600 | ₹1,497,600 |
| S-HNI (Min) | 14 | 16,800 | ₹1,612,800 |
| B-HNI (Min) | 67 | 80,400 | ₹7,718,400 |
Financial Statements Amount in ₹ Crore
| Metric | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Revenue | 105 | 100 | 76 |
| Profit After Tax | 13 | 11 | 7 |
| Net Worth | 36 | 23 | 12 |
| Total Assets | 70 | 41 | 28 |
| Reserves & Surplus | 18 | 23 | 12 |
| Total Borrowing | 0 | 0 | 1 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- Funding capital expenditure requirements for setting up of manufacturing facility for Nutraceutical Division – 22.60
- Funding capital expenditure requirements for setting up of manufacturing facility for Veterinary Food Division – 11.59
- Purchase of Machineries for Homecare and Cosmetic Division – 2.76
- General corporate purposes – 5.44
Company Overview
Incorporated in September 2020, Influx Healthtech Limited is a healthcare-focused company specialising in contract manufacturing. The company is a reliable CDMO, providing specialized services to clients in multiple industries.
The company has three manufacturing facilities in Thane, Maharashtra, each covering an area of 9,676 square feet, 13,000 square feet, and 14,000 square feet, respectively.
Product Portfolio:
- Tablets, Capsules, and Powders
- Liquid Orals and Softgels
- Lozenges, Jellies, and Gummies
- Oral Dispersible Films (ODFs)
- Effervescent Tablets and Liquid-Fill Capsules
- Candies and Gym/Sports Supplements
- Skin Care and Body Care Products
- Hair Care and Beard Care Solutions
- Face Masks and Soaps.
- Ayurvedic / Herbal formulations
- Veterinary Feed Supplements
- Homecare solutions
The Company aids Nutraceutical and Cosmetic firms with product development and manufacturing. It offers end-to-end services, including development, production, and regulatory support, enabling clients to focus on formulation and commercialization.
As of June 11, 2025, the company has 163 permanent employees on a payroll basis.
Competitive Strength
- Diversified Product Portfolio
- Diverse Clientele
- Stringent Quality Assurance/Quality Control
- Experienced and Qualified Promoters and Management team.